Crk knockdown reduced metastatic tumor burden in blood, liver, and lung together with reductions in tumor volume at the primary site and the number of circulating tumor cells following orthotopic injection of bladder cancer cells under the bladder muscle layer [45]. The gene discussed is CRK; the disease is urinary bladder carcinoma.